Juan D. Pedraza, MD
Tel. 914-770-3520
Assistant Professor of Psychiatry and Child Psychiatry
Faculty of the Graduate School of Biomedical Sciences
Icahn School of Medicine at Mount Sinai Medical Center
New York, New York
Dr. Pedraza is originally from South America. He completed General Psychiatry at Maimonides Medical Center in Brooklyn NY, and Child and Adolescent Psychiatry training at Mount Sinai Medical Center. Dr Pedraza is a highly regarded clinician with special expertise in the areas of ADHD, Aggression and Disruptive Behavior Disorders. Dr. Pedraza developed and directed the ADHD specialty Clinic at Mount Sinai Medical Center. Over the last few years he spent a significant amount of time supervising residents and fellows in psychopharmacology and new psychiatric evaluations.
He also has special expertise in treating anxiety disorders, autism spectrum disorder and mood disorders in children. Dr. Pedraza has been working within Mount Sinai’s ADHD division since he started his child psychiatry fellowship, and he has participated in multiple studies focusing on clinical and translational research. Recently he has focused on developing an innovative tool to help in the diagnosis of ADHD and related disorders. Dr. Pedraza has published multiple articles and book chapters on the treatment of ADHD and Disruptive Behavior Disorders in adults and children. He is also a certified ADHD evaluator for the NFL and Chief of Psychiatry at St. Joseph’s Wayne Hospital in NJ.
Dr. Pedraza is assistant professor of Psychiatry and Child Psychiatry at the Icahn School of Medicine and Faculty of the Graduate School of Biomedical Sciences at the Icahn School of Medicine – Mount Sinai Medical Center in NYC. Dr. Pedraza is board certified in Psychiatry and Neurology and Child and Adolescent Psychiatry.
Approach
Dr. Pedraza is a highly regarded teacher and clinician. He puts special emphasis on the individual characteristics of his patients and their families. As part of his individualized approach he conducts comprehensive evaluations that involve collaborating with families, neuropsychologists, schools, educational advisors and therapists from different disciplines. He conceptualizes every case from a bio-psycho-social perspective.
Dr. Pedraza is an expert psychopharmacologist. He has a conservative approach to medication management, always basing his treatment on the best evidence available in the literature and the most convenient treatment for each patient. Dr. Pedraza treats his patients with an eclectic approach using cognitive behavior psychotherapy, family therapy and dynamically oriented interventions when necessary. He frequently treats patients with behavior modification strategies and medication management in order to help patients and their families achieve the treatment goals.
Dr. Pedraza discusses every treatment plan and medication option thoroughly, describing clear and realistic goals. He puts special emphasis on establishing a close therapeutic relationship with the patient and the family. Dr. Pedraza is available for his patients every day of the week and he works closely and efficiently with other members of the patient’s treatment team.
The priority of the practice is to dedicate adequate time for every patient and every family. Dr. Pedraza does not accept any commercial insurance panel. He does participate as an out of network provider.
Awards
4D Technology Development Program Award
(2015)
Patients’ Choice Award
(2015)
Compassionate Doctor Recognition
(2015)
On-Time Doctor Award
(2015)
Research & Press
2015- Current
PRISMA. Initial proof of concept study. Mount Sinai Medical Center 4D Program Award
Role: PI
This study will pilot the application of innovative technology as an adjunctive diagnostic tool for ADHD
2/1/12-1/9/13
Improving identification of Attention-Deficit/Hyperactivity Disorder (ADHD) and Executive Function in parents of children diagnosed with ADHD using objective measures POND family foundation award, APSARD
Role: PI
This study described the prevalence of ADHD and EF deficits in 60 biological mothers of inner- city youth undergoing treatment for ADHD using state-of-the-art clinical and objective assessment measures. It provided new information regarding the role of the Quotient TM ADHD system as an adjunct tool for improving the sensitivity and specificity of ADHD diagnosis
2009
Research project on Omega-3 fatty acids as an adjunctive therapy for stimulants in children diagnosed with ADHD. Glaxo Smith Kline Collaborative grant.
Role: Co-I
Prospective, randomized, placebo controlled trial using Omega-3 fatty acids as an adjunctive therapy for children who were on stimulants for the treatment of ADHD
R01 MH070935 (Newcorn and Stein) NIMH 12/1/04- 6/31/12
Measuring and Predicting Response to Atomoxetine and Methylphenidate
Role: Study Physician
To evaluate the relative efficacy, tolerability and palatability of Concerta methylphenidate and ATX in the treatment of children and adolescents with ADHD, using a randomized, double blind, cross-over design
R01 MH070935-02S1 (Newcorn) NIMH 1/1/06-6/30/12
Methylphenidate and Atomoxetine in ADHD: fMRI Measures of Mechanisms and Response
Role: Study Physician
Functional magnetic resonance imaging (fMRI) used to better understand the neurobiological mechanisms of pharmacological treatments for ADHD
Shire Pharmaceuticals (IST; Newcorn) 7/1/2010-6/30/2013
Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents with ADHD: an fMRI Study of Brain Activation Pre and Post Treatment
Role: Study Physician
This study examined the mechanisms of action of Guanfacine extended release in the treatment of youth with ADHD using a pre/post fMRI design
Shire Pharmaceuticals (IST; Newcorn) 9/22/2010-1/31/2010
A Phase 3, Double-blind Placebo-controlled, Multicentre Randomized, Long-term Maintenance of Efficacy and Safety Study of Extended-release Guanfacine Hydrochloride in Children and Adolescents Ages 6-17 with Attention-deficit/ Hyperactivity Disorder
Role: Study Physician
This study evaluated the long-term maintenance of efficacy of SPD503 in children and adolescents (6-17) with attention-deficit/hyperactivity disorder (ADHD) who respond to an initial open-label, short-term treatment with SPD503.
A Combination of Scheduled Reduced Smoking (SGR) with Varenicline (VN) to Enhance Cessation (GCO#: 10-0879)
A Phase 3, Double-blind Placebo-controlled, Multicentre Randomized, Long-term Maintenance of Efficacy and Safety Study of Extended-release Guanfacine Hydrochloride in Children and Adolescents Ages 6-17 with Attention-deficit/ Hyperactivity Disorder
Role: Study Physician
To provide initial data on the efficacy of combined SGR+VN therapy with regard to smoking cessation, by assessing rates of abstinence and levels of smoking at 2 time points (4 and 12 weeks post quit) following a cessation attempt, in which smokers were randomized to receive either SGR+VN, SGR+Placebo Drug, Basic Advice+VN, or Basic Advice+Placebo Drug, in a 2 x 2 factorial design.
Papers
Juan D. Pedraza. Culturally competent approaches to diagnosing ADHD in Hispanic adults and overcoming cultural issues with patients and families. Journal of clinical Psychiatry. Volume 76- January 2015-Number 1.
Papers
Bédard, A.C., Schulz, K.P., Krone, B., Pedraza, J., DuHoux, S., Halperin, J.M., & Newcorn, J.H. (2015). Neural mechanisms underlying the therapeutic actions of guanfacine treatment in youth with ADHD: a pilot fMRI study. Psychiatry Research: Neuroimaging, 231(3), 353–356
Papers
Obsessive-compulsive disorder and comorbid attention-deficit/hyperactivity disorder: a complex diagnostic disentanglement and treatment. J Child Adolescent Psychopharmacology. 2013 Aug; 23(6):419-22. doi: 10.1089/cap.2013.2362. Pedraza JD, Coffey B
Papers
Psychosocial Aspects of Lung Cancer. Trastornos psicológicos y de la calidad de vida en pacientes con cancer de pulmón. Mauricio Murillo MD, Juan D Pedraza MD. Psico-oncologia vol. 3 – num 2-3. 2006 pag 377-392. Spain.
Papers
Robert S. Crawford, MD, Thomas K. Chung, MA, Juan D. Pedraza, MD, Thomas Hodgman BA, Michael Corey, MD, ad Richard P. Cambria, MD. Restenosis after Eversion (EV) vs. Patch Closure (PC) Carotid Endarterectomy (CEA) Journal of Vascular Surgery. 2007 Jul; 46(1):41-8.
Papers
Mark F. Conrad MD, Robert S. Crawford MD, Juan D. Pedraza MD, David H. Stone MD David C. Brewster MD, Glenn M. LaMuraglia MD, Michael Corey MD, S. P. Kalva MD, Sunny Abbara MD and Richard P CambriaMD. Long-Term Durability of Open Abdominal Aortic Aneurysm Repair. Journal of Vascular Surgery. 2007 Oct; 46(4):669 -75
Papers
Rostain AL, Diaz Y, Pedraza J. Solutions for treating Hispanic adults with ADHD. J Clin Psychiatry. 2015 Feb;76(2):170-3.
Papers
Rostain AL, Diaz Y, Pedraza J. Barriers to care for Hispanic adults with ADHD. J Clin Psychiatry. 2015 Jan;76(1):45-8; quiz 48.
Children of Parents with Substance Use Disorder
Iliyan Ivanov, John Leikauf, Juan Pedraza and Jeffrey Newcorn. In: Victor R. Preedy (Ed.)Neuropathology of Drug Addictions and Substance Misuse Volume 1: Foundations of Understanding, Tobacco, Alcohol, Cannabinoids and Opioids. Elsevier Inc. 2016.
Culturally competent approaches to diagnosing ADHD in Hispanic adults and overcoming cultural issues with patients and families.
Juan D. Pedraza. Journal of clinical Psychiatry. Volume 76-January 2015-Number 1.
Non-stimulant Treatment of ADHD. Pedraza, J and Newcorn, JH.
In: Adler, Wilens, Spencer (Eds.) Attention-Deficit Hyperactivity Disorder in Adults and Children. Cambridge University Press 2015
Functional genetic variations and their role in aggressive behavior in the context of disruptive behavior disorders
Advances in Psychology Research. Volume 95 Editors: Alexandra M.Columbus. Juan D. Pedraza, Iliyan Ivanov, Ozan Otoy, Jeffrey Newcorn. Mount Sinai Medical Center, New York, New York, USA, June 2012.
Conduct Disorder
Barnhill JW (ed): DSM-5 Clinical Cases. Arlington, VA, American Psychiatric Publishing (in press). Pedraza JD. Newcorn J.
Krone, B., Hildebrandt, T., San Giorgio, C., Palmero R., Zeranski, E., Davidow, J., Rajwan, E., Li, M., Roinstead, S., Pazmino, E., Kirschenbaum, A., Ivanov, I., Bedard, A-C., Pedraza, J.D., Halperin, J., Stein, M., Newcorn, J.H. (2016, January). Examination of Sluggish Cognitive Tempo Construct in Pediatric ADHD. Poster Presented Annual Meeting of APSARD; Washington, DC.
Krone, B; Hildebrandt, T; Stein, M; Bédard, AC; Ivanov, I; Pedraza JD.; Newcorn, J. (January, 2015) Moderated Mediation of ADHD: Role of ODD and Mood Lability in Treatment. Presented at the Annual Meeting of APSARD; Washington, DC
Duhoux S, Schulz KP, Krone B, B dard AC, Pedraza J, Adler, LA, White SF, Blair JR, Newcorn JH (2014, September). Neurobiological Basis of Response to Lisdexamfetamine (Vyvanse®) in Adults with ADHD. Annual Meeting of ASCP, Hollywood, Fla.
Pedraza, J.D., Krone, B., Bayon, E., Adler, L., Newcorn, J.H. (2014, January). Prevalence and Co-morbidity of ADHD in Hispanic and Non-Hispanic mothers of inner city youth Currently Undergoing Treatment for ADHD. Presented at the Annual Meeting of APSARD; Washington, DC
Pedraza, J.D., Krone, B., Bayon, E., Li, M., Duhoux S., Bedard A.C., Adler, L., Newcorn, J.H. (2013, September). Improving Identification of ADHD and Executive Function Deficits in Parents of Children Diagnosed With ADHD Using Objective Measures. Pond Family Foundation at the annual convention of APSARD, Washington DC.
Chang, R., Krone, B. Chen, A., Nomura, Y., Pedraza, J., Angarita, B., Bedard, A-C., Stein, M., Newcorn, J. . (2011, October). Social skills and functional status in youth with attention-deficit/hyperactivity disorder (ADHD) treated with methylphenidate and atomoxetine. Mount Sinai School of Medicine Student Research Day, New York, New York.
Areas of focus - 1/7
Child ADHD
(Attention-Deficit/Hyperactivity Disorder)
Attention Deficit/Hyperactivity Disorder (ADHD) is a condition which includes difficulties with attention, increased activity, and impulsive behavior. There are three different presentations; predominantly inattentive, predominantly hyperactive and combined. The symptoms have to begin in childhood and their must be impairment in two different settings. Estimates show that 11 percent of school-aged children and about 4 percent of adults have ADHD.
Areas of focus - 2/7
Disruptive Behavior Disorders
Oppositional defiant disorder and Conduct disorder
ODD: In children with Oppositional Defiant Disorder (ODD), there is an ongoing pattern of uncooperative, defiant, and hostile behavior toward authority figures that seriously interferes with the youngster's day to day functioning.
Areas of focus - 3/7
Conduct Disorder
A repetitive and persistent pattern of behavior in which the basic rights of others or major age- appropriate societal norms or rules are violated, as manifested by the presence of at least three of 15 DSM V criteria in the past 12 months, with at least one criterion present in the past 6 months.The disturbance in behavior causes clinically significant impairment in social, academic, or occupational functioning. If the individual is age 18 years or older, criteria are not met for antisocial personality disorder. The disorder can have onset during childhood, adolescence or unspecified onset.
Areas of focus - 4/7
Autism Spectrum Disorder
(ASD)
In Autism Spectrum Disorder the individual has significant deficits and Impairment in social reciprocity/communication and Stereotypic and repetitive behaviors. The Prevalence in the US(2009) was 1 in 150 children. Most recent estimates (2014) say that 1 in 45 of children aged 3-17 (2.22%) meet criteria for ASD.
Areas of focus - 5/7
Generalized Anxiety Disorder
(GAD)
Generalized anxiety disorder (GAD) is characterized by excessive and uncontrollable worry about a variety of events. It is often accompanied by physical symptoms such as headaches, muscular tension, restlessness, heart palpitations, and stomach upset. Children and adolescents with GAD may worry excessively about their performance and competence at school or in sporting events, about personal safety and the safety of family members, or about natural disasters and future events.
Areas of focus - 6/7
Major Depressive Disorder
(MDD)
Everyone, including children, goes through periods of feeling unhappy or listless. But if the feelings are very strong or persist for a long time, they might be caused by a medical problem. Major depression, or simply “depression,” is a serious condition that can take over your child’s mood and thoughts. The good news is that awareness and intervention from parents or other adults can help children with depression live normal and happy lives. A child with depression typically feels a constant sense of discouragement, a loss of self-worth and little interest in activities he used to enjoy. It’s important to understand that your child, or anyone with depression, cannot just "snap out of it" or make himself feel better. Without treatment, symptoms can last for months or even years.
Areas of focus - 7/7
Obsessive Compulsive Disorder
(OCD)
Obsessive-compulsive disorder (OCD) is a condition in which a person has an unreasonable thought, fear, or worry that he/she tries to manage by performing a ritual activity to reduce the anxiety. Frequently occurring disturbing thoughts or images are called obsessions, and the repeated rituals performed to try to prevent or dispel them are called compulsions.